Family Medicine · Bethel Park, PA
NPI
1104876473
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1000 Higbee Dr, Suite 104
Bethel Park, PA, 15102
Phone (412) 833-6176
Groups this clinician bills Medicare through
Medicare paid, 2024
$172K
4,163 services
Medicare patients, 2024
395
Average age 74
Drug cost, 2024
$2.0M
18,619 prescriptions
Company payments, 2025
$1,003
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natalie V Furlong was code J0897 (injection, denosumab, 1 mg), 1,800 times for 20 patients. In total Natalie V Furlong billed 4,163 services in 40 codes, and Medicare paid $172K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,800 | 20 | $20.72 | $37K |
| 99214 Office E&M - Established | Office | 624 | 336 | $80.91 | $50K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 233 | 233 | $126.55 | $29K |
| 90673 Vaccine Product | Office | 96 | 96 | $81.82 | $7,855 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 86 | 86 | $18.29 | $1,573 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 86 | 86 | $24.89 | $2,141 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 67 | 67 | $18.28 | $1,225 |
| 99350 Home E&M - New and Established | Office | 66 | 32 | $129.27 | $8,532 |
| 96372 Injection Administration | Office | 49 | 24 | $10.65 | $522 |
| 90677 Vaccine Product | Office | 28 | 28 | $290.11 | $8,123 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 25 | 25 | $161.69 | $4,042 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 22 | 22 | $161.73 | $3,558 |
| 93000 Electrocardiogram | Office | 17 | 16 | $9.80 | $167 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 14 | 12 | $217.28 | $3,042 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 12 | 12 | $160.03 | $1,920 |
By year: 2022 $146K for 3,296 services; 2023 $147K for 3,418 services; 2024 $172K for 4,163 services.
Medicare prescription drug claims, 2024
In 2024, the drug Natalie V Furlong prescribed most often to Medicare patients was Amlodipine Besylate, with 876 prescriptions and refills. In total Natalie V Furlong wrote 18,619 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 876 | 2,135 | 221 | $4,773 |
| Levothyroxine Sodium Generic | 839 | 2,147 | 214 | $9,520 |
| Atorvastatin Calcium Generic | 778 | 1,967 | 194 | $7,271 |
| Rosuvastatin Calcium Generic | 717 | 1,934 | 211 | $8,933 |
| Pantoprazole Sodium Generic | 581 | 1,378 | 162 | $6,255 |
| Gabapentin Generic | 490 | 836 | 124 | $5,846 |
| Losartan Potassium Generic | 459 | 1,256 | 134 | $4,537 |
| Lisinopril Generic | 448 | 1,289 | 125 | $2,674 |
| Hydrochlorothiazide Generic | 390 | 1,005 | 106 | $1,235 |
| Metformin Hcl Generic | 365 | 961 | 110 | $2,682 |
| Famotidine Generic | 364 | 800 | 98 | $3,977 |
| Eliquis Apixaban | 345 | 592 | 73 | $329K |
| Pravastatin Sodium Generic | 339 | 971 | 100 | $3,908 |
| Metoprolol Succinate Generic | 328 | 857 | 90 | $4,426 |
| Escitalopram Oxalate Generic | 301 | 618 | 75 | $2,031 |
Brand drugs: 2,372 claims; generic drugs: 16,128 claims; opioid claims: 360.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natalie V Furlong $1,003 ($1,003 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $454.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $454 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $83 |
| Novo Nordisk Inc NVO | 4 | $81.08 |
| GlaxoSmithKline, LLC. GSK | 3 | $47.12 |
| Lilly USA, LLC LLY | 2 | $47.02 |
| Amgen Inc. AMGN | 3 | $44.8 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $39.85 |
| Abiomed JNJ | 1 | $32.69 |
| Pfizer Inc. PFE | 2 | $30.58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $24.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.